PDP IV – Advancing the clinical development of placental malaria vaccines
This project is implemented under the PDP IV programme by the European Vaccine Initiative (EVI).
EVI's mission is to reduce the burden of poverty-related infectious diseases through the development of new, safe, effective, and affordable vaccines against diseases that disproportionately affect low- and middle-income countries (LMICs). Vulnerable populations, notably children and women of childbearing age, are the target groups of EVI's efforts.

Project number
NL-KVK-27378529-PDP22DE02Total budget
€ 17,247,700Countries
Benin, Burkina Faso, Malawi, MaliProject status
ImplementationBudget spent
47.50 % spent
Tied status
UntiedStartdate:
Enddate:
Contact
iati@rvo.nlProject partners
European Vaccine Initiative, Netherlands Enterprise AgencySectors
Malaria controlType | Provider | Provider ref. | Receiver | Receiver ref. | Value (€) | Date | Value date |
---|---|---|---|---|---|---|---|
Incoming Funds | 17,247,700.00 | 16-12-2022 | 16-12-2022 | ||||
Outgoing Commitment | European Vaccine Initiative | 17,247,700.00 | 16-12-2022 | 16-12-2022 | |||
Disbursement | European Vaccine Initiative | 1,638,531.50 | 22-12-2022 | 22-12-2022 | |||
Disbursement | European Vaccine Initiative | 1,638,531.50 | 18-07-2023 | 18-07-2023 | |||
Disbursement | European Vaccine Initiative | 1,638,531.50 | 22-01-2024 | 22-01-2024 | |||
Disbursement | European Vaccine Initiative | 1,638,531.50 | 16-07-2024 | 16-07-2024 | |||
Disbursement | European Vaccine Initiative | 1,638,531.50 | 11-02-2025 | 11-02-2025 |